Efficacy of antiplatelets in deep venous thrombosis
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.
Pharmacists in 2023: roles and remuneration
Better remuneration and career support are key to the future of pharmacists’ roles.
The pharmacy profession provides a much broader range of health services...
Consultant pharmacist excellence awarded
Two pharmacists were honoured at PSA’s Consultant Pharmacist Conference (CPC26), held from 29–31 May 2026 on the Gold Coast.
Pharmacists in 2023 – unlocking the future of pharmacy
A major new PSA report, Pharmacists in 2023, reveals a roadmap for the changes needed to ensure the profession’s potential is realised – and...
Bushfire crisis brings out the best in pharmacists
It has been a tough start to 2020 for many Australians. The bushfire crisis has engulfed Australia, affecting virtually all states and territories.
Supporting patients to quit vaping: an important role for pharmacists
With vaping rates rising and regulatory changes reshaping access, pharmacists play an increasingly important role.













